Stock listing
NASDAQ:GWPH GW Pharmaceuticals plc Stock
Follow GW Pharmaceuticals plc into a list and get an email when it puts out news.
Last close · NASDAQ:GWPH
$218.96 USD
Close on May 5, 2021 · No longer trades
- Lowest – highest close
- $8.51 – $219.28 USDSince May 1, 2013 · lowest Jun 11, 2013 · highest May 3, 2021
Delisted NASDAQ:GWPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GWPH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
GW Pharmaceuticals plc on 6ix
- Decks
- 11 decks · latest Feb 26, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (February 2021) | Merger or acquisition | 12 slides | Feb 26, 2021 |
| FY2020 Earnings Presentation | Earnings | 10 slides | Feb 23, 2021 |
| Merger or Acquisition (February 2021) | Merger or acquisition | 21 slides | Feb 4, 2021 |
| Shareholder Meeting (June 2019) | Shareholder meeting | 28 slides | Jun 13, 2019 |
| 37th Annual J.P. Morgan Healthcare Conference (January 2019) | Conference | 23 slides | Jan 7, 2019 |
| Shareholder Meeting (March 2018) | Shareholder meeting | 33 slides | Mar 14, 2018 |
| Technical Presentation (December 2017) | Technical | 24 slides | Dec 4, 2017 |
| Shareholder Meeting (March 2017) | Shareholder meeting | 35 slides | Mar 14, 2017 |
| Investor Presentation (January 2017) | Investor deck | 33 slides | Jan 9, 2017 |
| Investor Day (October 2014) | Investor day | 118 slides | Oct 15, 2014 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2014) | Technical | 12 slides | Jun 17, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alicia Secor Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past) | Director · Oct 1, 2018 – May 5, 2021 · Past |
| James Noble Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2022 · Past) | Director · Oct 1, 2018 – May 5, 2021 · Past |
| Douglas B. Snyder Other companies: IDEAYA Biosciences, Inc. (Chief Legal Officer · Since at least Sep 18, 2024) | Chief Legal Officer · Oct 1, 2018 – May 5, 2021 · Past |
| Scott Giacobello Other companies: Whitehawk Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 28, 2021) | Chief Financial Officer · Oct 1, 2018 – May 5, 2021 · Past |
Log in to ask 6ix AI your own questions about GW Pharmaceuticals plc.